調查批次:CHT2018-01 | 檢體寄出日期:2018-06-04 | 報告回收截止日期:2018-06-11 | 回收份數:22 |
T3 檢驗院際品管調查結果: | ||
2.歷次品管檢體 T3 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 1 |
2 |
5 |
221 |
21.00 |
10.5 |
1.3 |
1.1 |
44 |
302 |
42.00 |
16.2 |
2.0 |
1.5 |
67 |
RH07b | RH07 | 4 |
2 |
3 |
166 |
-34.00 |
-17.0 |
-2.1 |
-1.0 |
-71 |
224 |
-36.00 |
-13.8 |
-1.7 |
-0.9 |
-58 |
RH14 | RH14 | 4 |
2 |
3 |
190 |
-10.00 |
-5.0 |
-0.6 |
-0.1 |
-21 |
234 |
-26.00 |
-10.0 |
-1.3 |
-0.6 |
-42 |
RH15 | RH15 | 4 |
2 |
5 |
224 |
24.00 |
12.0 |
1.5 |
1.2 |
50 |
291 |
31.00 |
11.9 |
1.5 |
1.2 |
50 |
CL009 | CL009 | 3 |
2 |
5 |
191 |
-9.00 |
-4.5 |
-0.6 |
-0.0 |
-19 |
248 |
-12.00 |
-4.6 |
-0.6 |
-0.2 |
-19 |
CL010 | CL010 | 3 |
2 |
5 |
206 |
6.00 |
3.0 |
0.4 |
0.5 |
13 |
258 |
-2.00 |
-0.8 |
-0.1 |
0.1 |
-3 |
CL012 | CL012 | 4 |
2 |
3 |
176 |
-24.00 |
-12.0 |
-1.5 |
-0.6 |
-50 |
241 |
-19.00 |
-7.3 |
-0.9 |
-0.4 |
-30 |
CL014a | CL014 | 4 |
2 |
3 |
160 |
-40.00 |
-20.0 |
-2.5 |
-1.2 |
-83 |
234 |
-26.00 |
-10.0 |
-1.3 |
-0.6 |
-42 |
Median of RIA Group |
191 |
245 |
||||||||||||||
Range of RIA Group |
160 - 224 |
224 - 302 |
||||||||||||||
Robust mean of RIA Group |
192 ( n = 8 ) |
254 ( n = 8 ) |
||||||||||||||
Robust SD of RIA Group |
27.2 |
32.1 |
||||||||||||||
CV of RIA Group |
14.2% |
12.6% |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 8 |
4 |
9 |
212 |
12.00 |
6.0 |
0.8 |
-0.2 |
25 |
264 |
4.00 |
1.5 |
0.2 |
0.0 |
6 |
RH02c | RH02 | 2 |
4 |
1 |
205 |
5.00 |
2.5 |
0.3 |
-0.5 |
10 |
252 |
-8.00 |
-3.1 |
-0.4 |
-0.4 |
-13 |
RH06 | RH06 | 4 |
4 |
9 |
197 |
-3.00 |
-1.5 |
-0.2 |
-0.8 |
-6 |
261 |
1.00 |
0.4 |
0.0 |
-0.1 |
2 |
RH07a | RH07 | 3 |
4 |
2 |
195 |
-5.00 |
-2.5 |
-0.3 |
-0.9 |
-10 |
242 |
-18.00 |
-6.9 |
-0.9 |
-0.7 |
-29 |
RH12 | RH12 | 8 |
4 |
2 |
205 |
5.00 |
2.5 |
0.3 |
-0.5 |
10 |
253 |
-7.00 |
-2.7 |
-0.3 |
-0.4 |
-11 |
RH15b | RH15b | 7 |
4 |
13 |
221 |
21.00 |
10.5 |
1.3 |
0.2 |
44 |
279 |
19.00 |
7.3 |
0.9 |
0.5 |
30 |
RH19 | RH19 | 2 |
4 |
2 |
202 |
2.00 |
1.0 |
0.1 |
-0.6 |
4 |
230 |
-30.00 |
-11.5 |
-1.4 |
-1.1 |
-48 |
RH20 | RH20 | 4 |
4 |
7 |
246 |
46.00 |
23.0 |
2.9 |
1.3 |
96 |
309 |
49.00 |
18.8 |
2.4 |
1.5 |
79 |
CL005 | CL005 | 2 |
4 |
9 |
195 |
-5.00 |
-2.5 |
-0.3 |
-0.9 |
-10 |
265 |
5.00 |
1.9 |
0.2 |
0.0 |
8 |
CL006a | CL006 | 7 |
4 |
1 |
264 |
64.00 |
32.0 |
4.0 |
2.1 |
133 |
211 |
-49.00 |
-18.8 |
-2.4 |
-1.7 |
-79 |
CL008 | CL008 | 4 |
4 |
2 |
211 |
11.00 |
5.5 |
0.7 |
-0.2 |
23 |
262 |
2.00 |
0.8 |
0.1 |
-0.1 |
3 |
CL011 | CL011 | 2 |
4 |
13 |
228 |
28.00 |
14.0 |
1.8 |
0.5 |
58 |
297 |
37.00 |
14.2 |
1.8 |
1.1 |
59 |
CL013b | CL013b | 7 |
4 |
1 |
207 |
7.00 |
3.5 |
0.4 |
-0.4 |
15 |
254 |
-6.00 |
-2.3 |
-0.3 |
-0.3 |
-10 |
CL015b | CL015b | 3 |
4 |
7 |
261 |
61.00 |
30.5 |
3.8 |
2.0 |
127 |
323 |
63.00 |
24.2 |
3.0 |
1.9 |
101 |
Median of CLIA Group |
209 |
262 |
||||||||||||||
Range of CLIA Group |
195 - 264 |
211 - 323 |
||||||||||||||
Robust mean of CLIA Group |
216 ( n = 14 ) |
264 ( n = 14 ) |
||||||||||||||
Robust SD of CLIA Group |
22.6 |
30.9 |
||||||||||||||
CV of CLIA Group |
10.5% |
11.7% |
||||||||||||||
Median of All Labs |
206 |
256 |
||||||||||||||
Range of All Labs |
160 - 264 |
211 - 323 |
||||||||||||||
Robust mean of All Labs |
207 ( n = 22 ) |
260 ( n = 22 ) |
||||||||||||||
Robust SD of All Labs |
24.7 |
30.7 |
||||||||||||||
CV of All Labs |
11.9% |
11.8%
|
||||||||||||||
Certified assigned value ( Xa )( ng/dL ) |
200 |
260 |
||||||||||||||
Expanded uncertainty ( Ua ) |
2.02 |
2.60 |
||||||||||||||
Relative expanded uncertainty |
1.0% |
1.0% |
||||||||||||||
Coverage factor k |
2.5 |
2.6 |
||||||||||||||
Effective degrees of freedom veff |
6 |
5 |
||||||||||||||
SD for proficiency assessment ( σp ) |
16.0 |
20.8 |
||||||||||||||
Adjusted SD for proficiency assessment ( σp ' ) |
- |
- |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH15b, RH19, RH20, CL005, CL006a, CL008, CL011, CL013b, CL015b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL006a, CL013b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL014a, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, |
Siemens ADVIA Centaur |
7 |
RH20, CL015b, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
RH15b, CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 臺北信維郵局第 624 信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2018-06-12